Humankind Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,439
Closed -$1.62M 60
2025
Q3
$1.62M Sell
21,439
-1,314
-6% -$90.1K 0.37% 35
2025
Q2
$1.57M Buy
22,753
+11,126
+96% +$730K 0.38% 36
2025
Q1
$788K Sell
11,627
-2,028
-15% -$121K 0.2% 66
2024
Q4
$613K Buy
13,655
+1,621
+13% +$90.9K 0.16% 72
2024
Q3
$757K Buy
12,034
+479
+4% +$27.9K 0.27% 59
2024
Q2
$682K Buy
11,555
+7,505
+185% +$469K 0.18% 64
2024
Q1
$323K Sell
4,050
-127
-3% -$9.7K 0.09% 107
2023
Q4
$330K Sell
4,177
-125
-3% -$8.9K 0.1% 101
2023
Q3
$300K Buy
4,302
+101
+2% +$7.16K 0.12% 93
2023
Q2
$290K Sell
4,201
-4,825
-53% -$343K 0.11% 98
2023
Q1
$671K Buy
9,026
+805
+10% +$67.5K 0.28% 57
2022
Q4
$766K Buy
8,221
+590
+8% +$56.9K 0.33% 49
2022
Q3
$728K Buy
7,631
+666
+10% +$65.9K 0.35% 44
2022
Q2
$645K Buy
6,965
+1,332
+24% +$130K 0.31% 50
2022
Q1
$570K Sell
5,633
-293
-5% -$30.8K 0.23% 56
2021
Q4
$611K Buy
5,926
+81
+1% +$7.49K 0.77% 40
2021
Q3
$496K Buy
5,845
+597
+11% +$50K 0.76% 43
2021
Q2
$438K Buy
5,248
+1,814
+53% +$149K 0.78% 43
2021
Q1
$258K Buy
+3,434
New +$250K 0.79% 50

Other funds holding CVS

Humankind Investments's CVS Position: Q4 2025 in Review

Humankind Investments sold out of CVS Health (CVS) in Q4 2025, closing a stake of 21,439 shares — an estimated $1.62M sold.

Humankind Investments first reported a position in CVS in Q1 2021 and held it in 19 quarters. The position peaked at $1.62M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Humankind Investments reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 21,439 CVS Health shares in Q4 2025, an estimated $1.62M.
  • Humankind Investments first reported a position in CVS Health in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's CVS Health position peaked at $1.62M in Q3 2025.
  • 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.